IL67411A0 - Crystalline human leukocyte interferon,its production and pharmaceutical compositions containing it - Google Patents

Crystalline human leukocyte interferon,its production and pharmaceutical compositions containing it

Info

Publication number
IL67411A0
IL67411A0 IL67411A IL6741182A IL67411A0 IL 67411 A0 IL67411 A0 IL 67411A0 IL 67411 A IL67411 A IL 67411A IL 6741182 A IL6741182 A IL 6741182A IL 67411 A0 IL67411 A0 IL 67411A0
Authority
IL
Israel
Prior art keywords
human leukocyte
production
leukocyte interferon
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL67411A
Original Assignee
Sparamedica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sparamedica Ag filed Critical Sparamedica Ag
Publication of IL67411A0 publication Critical patent/IL67411A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/555Interferons [IFN]
    • C07K14/56IFN-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

(For the Contracting States : BE, CH, DE, FR, GB, IT, LI, LU, NL, SE) 1. Human leukocyte interferon (IFN-alpha in crystalline form. (For the Contracting State AT) 1. A process for the manufacture of human leukocyte interferon in crystalline form, characterized by treating an aqueous solution of the interferon at a concentration of at least about 0.2 mg/ml with polyethylene glycol (PEG).
IL67411A 1981-12-07 1982-12-03 Crystalline human leukocyte interferon,its production and pharmaceutical compositions containing it IL67411A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32787681A 1981-12-07 1981-12-07

Publications (1)

Publication Number Publication Date
IL67411A0 true IL67411A0 (en) 1983-05-15

Family

ID=23278463

Family Applications (1)

Application Number Title Priority Date Filing Date
IL67411A IL67411A0 (en) 1981-12-07 1982-12-03 Crystalline human leukocyte interferon,its production and pharmaceutical compositions containing it

Country Status (12)

Country Link
EP (1) EP0083734B1 (en)
JP (1) JPS58164597A (en)
AT (1) ATE18410T1 (en)
AU (1) AU551407B2 (en)
CA (1) CA1209038A (en)
DE (1) DE3269727D1 (en)
DK (1) DK159164C (en)
IE (1) IE54374B1 (en)
IL (1) IL67411A0 (en)
NZ (1) NZ202698A (en)
PH (1) PH20413A (en)
ZA (1) ZA828917B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5441734A (en) * 1993-02-25 1995-08-15 Schering Corporation Metal-interferon-alpha crystals
CN1245215C (en) 2001-02-28 2006-03-15 四川省生物工程研究中心 Recombinant super-compound interferon used as hepatitis B surface antigen and e antigen inhibitor
US7585647B2 (en) 2003-08-28 2009-09-08 Guangwen Wei Nucleic acid encoding recombinant interferon

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA796175B (en) * 1978-11-24 1980-11-26 Hoffmann La Roche Purified proteins and process therefor

Also Published As

Publication number Publication date
CA1209038A (en) 1986-08-05
AU551407B2 (en) 1986-05-01
ZA828917B (en) 1983-09-28
ATE18410T1 (en) 1986-03-15
JPH0477000B2 (en) 1992-12-07
PH20413A (en) 1987-01-05
AU9115582A (en) 1983-06-16
EP0083734B1 (en) 1986-03-05
DK159164B (en) 1990-09-10
NZ202698A (en) 1986-02-21
JPS58164597A (en) 1983-09-29
DK159164C (en) 1991-02-11
EP0083734A1 (en) 1983-07-20
DE3269727D1 (en) 1986-04-10
IE822882L (en) 1983-06-07
IE54374B1 (en) 1989-09-13
DK538482A (en) 1983-06-08

Similar Documents

Publication Publication Date Title
AU562938B2 (en) 7, 10, 13, 16 docosatetraenoic acid composition
ZA907338B (en) Thienylcarboxylates of amino alcohols
EP0614913A3 (en) Dynorphin derivatives.
DE3566545D1 (en) 2-substituted-1,3-propylidenediphosphonate derivatives, the process for their preparation and pharmaceutical compositions containing them
GR3006807T3 (en)
DE3462852D1 (en) Medicament preparation for external use comprising adenosin for the treatment of herpes
IL67411A0 (en) Crystalline human leukocyte interferon,its production and pharmaceutical compositions containing it
FI903030A0 (en) A process for preparing a pharmaceutical composition containing a polyprenyl compound
EP0080940A3 (en) Derivatives of 2-phenyl-morpholine and their uses as medicines
ZA857721B (en) Process for treatment of rheumatic diseases
RO84910A (en) PROCESS FOR THE PREPARATION OF 6-AMINOALCYLPENYLICANIC ACID DERIVATIVES OF 1,1-DIOXIDE
EP0410652A3 (en) Improvement of excretion of potassium ion by prostanoic acid derivatives
PT83192B (en) Process for preparing unsaturated compounds useful in the treatment of cardiovascular phatological conditions containing 1,4-di-hydropiridine-3,5-dicarboxylic acid derivatives
ATE43606T1 (en) COMPOUNDS WITH CARDIOTROPIC ACTIVITY, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
GR3000758T3 (en) Pharmaceutical compositions for the treatment of intermittent claudication
PH20720A (en) Oxytetracyclin solutions and process for their preparation
FR2515040B1 (en)
ATE53384T1 (en) 3-MERCAPTO-2-OXO-1-PYRROLIDINEACETIC ACID DERIVATIVES PROCESSES FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.

Legal Events

Date Code Title Description
RH Patent void